相似文献/References:
[1]刘刚,卢光琇. 湖南汉族人群CTLA4 基因+49G/A 多态性与乙肝感染和乙肝源性肝癌相关性的初步研究[J].南方医科大学学报,2010,(08):1838.
LIU Gang,LU Guang-xiu.Association of CTLA4 gene +49G/A polymorphism with HBV infection and HBV-relatedhepatocellular carcinoma in Hunan Han population[J].Journal of Southern Medical University,2010,(06):1838.
[2]赵金红,王健,江水清,等.慢性乙型肝炎患者CXC趋化因子Mig的表达[J].南方医科大学学报,2006,(11):1589.
ZHNA Jin-hong,WANG Jian,JIANG Shui-qing,et al.Expression of chemokine monokine induced by interferon-γ in patients with chronic hepatitis B[J].Journal of Southern Medical University,2006,(06):1589.
[3]于宏,曹治宸,耿建英,等.干扰素α治疗慢性乙型肝炎患者肝纤维化的实验研究[J].南方医科大学学报,2005,(11):1409.
YU Hong,CAO Zhi-chen,GENG Jian-ying,et al.Effect of interferon alpha on liver fibrosis in patients with chronic hepatitis B[J].Journal of Southern Medical University,2005,(06):1409.
[4]张明霞,覃国琦,李峰,等.脾脏肿大慢加急性肝衰竭病人的临床特点[J].南方医科大学学报,2014,(09):1310.
[5]刘颖,樊蓉,陈简,等.慢性乙型肝炎病毒感染相关肝硬化患者的肾功能及危险因素分析[J].南方医科大学学报,2014,(04):472.
[6]王欣欣,袁国盛,赖静兰,等.HBeAg阳性慢性乙型肝炎患者干扰素治疗24周应答不佳时的治疗方案[J].南方医科大学学报,2015,(06):807.
[7]杨年欢,袁国盛,周宇辰,等.恩替卡韦联合复方鳖甲软肝片治疗慢性乙型肝炎肝纤维化96周的临床疗效[J].南方医科大学学报,2016,(06):775.
[8]李梵,闫涛,李克,等.血浆游离DNA用于判断乙型肝炎相关慢加急性肝衰竭的预后—先锋试验结果[J].南方医科大学学报,2014,(02):147.